This is a comprehensive, evidence-backed answer. Here it is:
Can a Perfect HbA1c Mask Underlying Insulin Resistance?
Yes - and this is one of the most clinically important concepts in metabolic medicine.
First, let's calculate his BMI:
- Height: 180 cm, Weight: 94 kg
- BMI = 94 / (1.80)² = 29.0 kg/m² - Overweight (just below the obesity threshold of 30)
- For South/Southeast Asian populations, the WHO-recommended cutoff for obesity risk is BMI ≥ 23 kg/m², which means he is already in the obese risk category by Asian standards.
The Physiology: Why Blood Sugar Can Look Perfect Despite Insulin Resistance
Harrison's Principles of Internal Medicine (22nd Ed., 2025) explains this precisely:
"In the early stages of the disorder, glucose tolerance remains near-normal, despite insulin resistance, because the pancreatic beta cells compensate by increasing insulin output... The onset of insulin resistance is heralded by postprandial hyperinsulinemia, which is followed by fasting hyperinsulinemia and ultimately by hyperglycemia."
This is the compensated phase of insulin resistance. The sequence is:
Step 1: Insulin resistance develops (muscle/liver/fat don't respond normally)
↓
Step 2: Pancreas secretes MORE insulin to overcome resistance
↓
Step 3: Blood glucose stays normal → HbA1c looks "perfect"
↓
Step 4: Eventually beta cells exhaust → glucose starts rising → Prediabetes → T2DM
According to Fuster & Hurst's The Heart (15th Ed.):
"Insulin resistance is the predominant defect in more than 90% of patients with T2D, often preceding a diagnosis of T2D by 10 to 15 years."
So his normal glucose values are NOT reassuring on their own when his BMI is 29 (obese by Asian standards), he has borderline-low HDL (39 mg/dL), and he has been at this weight for 6 months. These are classical features of insulin resistance syndrome even with perfect glucose numbers.
His Specific Risk Profile
| Finding | Significance |
|---|
| BMI 29 kg/m² (Asian BMI > 23 = obesity risk) | Primary driver of insulin resistance |
| HDL 39 mg/dL (below 40) | Classic marker of insulin resistance / metabolic syndrome |
| Triglycerides 50 mg/dL (very low) | Reassuring - does not suggest dyslipidemia of insulin resistance yet |
| FBS 86, PPBS 100, HbA1c 5.0% | Euglycemic - but could reflect compensatory hyperinsulinemia |
| LDL 98, Total cholesterol 150 | Excellent |
The low HDL with overweight status is the key clue here - this combination is a well-established early marker of metabolic syndrome and insulin resistance, even before glucose rises.
How to Test for Insulin Resistance
The gold standard is the euglycemic hyperinsulinemic clamp (research tool, not practical). In clinical practice:
1. HOMA-IR (Homeostatic Model Assessment of Insulin Resistance)
HOMA-IR = [Fasting Serum Insulin (µU/mL) × Fasting Glucose (mg/dL)] / 405
- HOMA-IR < 1.0 = insulin sensitive
- HOMA-IR 1.0 - 1.9 = early insulin resistance
- HOMA-IR ≥ 2.0 = significant insulin resistance
- (From Fuster & Hurst's The Heart, 15th Ed.: "HOMA-IR predictive of CVD, with a one-unit increase associated with a 5.4% increased risk")
What to order: Fasting insulin level (along with the fasting glucose already tested). His FBS is 86 mg/dL - if fasting insulin comes back elevated (say > 10-15 µU/mL), HOMA-IR will flag insulin resistance despite his "perfect" HbA1c.
2. Fasting Insulin Level alone - if > 15 µU/mL in a fasting state, strong evidence of compensatory hyperinsulinemia.
3. Oral Glucose Tolerance Test (OGTT) with insulin levels - measures both glucose AND insulin at 0, 30, 60, 90, 120 min. An exaggerated insulin spike to maintain normal glucose is the hallmark of early insulin resistance.
Can He Prevent Diabetes if Insulin Resistance is Confirmed?
Absolutely - and this is exactly the right time to intervene.
The landmark Diabetes Prevention Program (DPP) trial (cited in Fuster & Hurst's and Textbook of Family Medicine 9e) showed:
- Lifestyle modification (caloric restriction + exercise) reduced progression to T2DM by 58% over 4 years
- Metformin reduced progression by 31%
- Every 1 kg of weight loss = 16% reduction in T2DM risk
- Maximal benefit seen at 7-10% body weight loss (for him: losing ~6.5-9.5 kg, i.e., getting to 84-87 kg)
- The benefit persisted at 10-year follow-up
At his current stage (euglycemic, early phase), intervention is dramatically more effective than waiting for glucose to rise.
Practical Recommendations for His Case
Tests to Order Now
- Fasting Serum Insulin - single most useful test
- Calculate HOMA-IR once insulin result is available
- Optional: OGTT with insulin curve (if insulin is borderline)
If Insulin Resistance is Confirmed: Target These
| Intervention | Expected Benefit |
|---|
| Lose 6-9 kg (7-10% of body weight) | ~80% reduction in diabetes risk |
| 150 min/week aerobic exercise | Raises HDL, improves insulin sensitivity |
| Reduce refined carbs/processed sugars | Reduces postprandial insulin demand |
| Resistance/strength training | Increases muscle glucose uptake (GLUT-4) |
| Adequate sleep (7-8 hrs) | Poor sleep independently worsens insulin sensitivity (RCT evidence, PMID 37955852) |
| Consider Metformin (if HOMA-IR high, physician decision) | 31% diabetes risk reduction |
Even if Insulin Resistance is Normal
At his BMI and age, annual monitoring is warranted - recheck fasting insulin, FBS, HbA1c, and lipids every year.
Bottom Line
His perfect HbA1c of 5.0% does not rule out insulin resistance - it may in fact be because of compensatory hyperinsulinemia that his glucose is so well controlled. Given his overweight status (BMI 29, obese by Asian standards), borderline-low HDL, and 6-month weight plateau, testing fasting insulin and calculating HOMA-IR is the next logical step. If insulin resistance is confirmed, he is in the best possible window to prevent T2DM through lifestyle change - a window that may only stay open for another 5-15 years.
This is for informational purposes. His treating physician should order and interpret the insulin studies in clinical context.